Your browser doesn't support javascript.
Characterizing COVID-19 severity, epidemiology and SARS-CoV-2 genotypes in a regional business hub of China.
Yan, Yan; Liu, Bin; Ding, Hui; Wang, Xu; Dai, Yaping; Ding, Difei; Yu, Hui; Sha, Mingchao; Lui, Chunyan; Chantsalmaa, Davgadorj; Qiu, Yuanwang; Huang, Lihua; Hu, Qinxue.
  • Yan Y; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China; The International Joint Research Laboratory for Infection and Immunity (China-Germany), Jiangnan University, Wuxi, China; Hepatology Institu
  • Liu B; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Ding H; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Wang X; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Dai Y; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Ding D; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Yu H; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Sha M; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Lui C; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Chantsalmaa D; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Qiu Y; The International Joint Research Laboratory for Infection and Immunity (China-Germany), Jiangnan University, Wuxi, China; Hepatology Institute of Wuxi, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China. Electronic address:
  • Huang L; The International Joint Research Laboratory for Infection and Immunity (China-Germany), Jiangnan University, Wuxi, China; Hepatology Institute of Wuxi, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China. Electronic address:
  • Hu Q; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China; Institute for Infection and Immunity, St. George's, University of London, London, U.K.. Electronic address: qhu@wh.iov.cn.
J Infect ; 82(2): 282-327, 2021 02.
Article in English | MEDLINE | ID: covidwho-728707
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Year: 2021 Document Type: Article